Navigation Links
Takeda to Create Global Centers of Excellence
Date:3/30/2009

ablished subsidiary in Asia.

Also effective April 1, 2009, Alan MacKenzie will assume the role of EVP, International Operations, responsible for all international (ex-Japan) commercial operations in the United States, Europe, and Asia, as well as global medical affairs and international marketing. The creation of the EVP, International Operations role enhances Takeda's globalization efforts and allows for more streamlined commercial decision making. The EVP, International Operations will be based in the United States at Takeda's Deerfield, Illinois headquarters.

Takeda Pharmaceuticals North America, Inc., Takeda Pharmaceuticals Europe Limited, and Takeda Pharmaceuticals Asia Private Limited will report to EVP, International Operations.

Formerly President and CEO of Takeda Pharmaceuticals North America, Inc. and Executive Vice President of Takeda America Holdings, Inc., Mr. MacKenzie has been with the Takeda family of companies for 24 years. He was a founding executive of Takeda Pharmaceuticals North America, Inc. and past President of TAP Pharmaceutical Products Inc.

Shinji Honda will replace Mr. MacKenzie as CEO, Takeda Pharmaceuticals North America, Inc. Mr. Honda joined Takeda in 1981 and has held a variety of roles in the global organization including Executive Vice President of TAP Pharmaceutical Products Inc. and head of the U.S. Operations Department. Most recently, Mr. Honda was the General Manager of the Overseas Business Planning Department.

Erich Brunn, Ph.D. will continue in his role as CEO of Takeda Pharmaceuticals Europe Limited. Dr. Brunn is responsible for oversight of pan-European sales and marketing. Dr. Brunn was previously President of Takeda Pharma GmbH, a wholly owned subsidiary of Takeda in Germany.

Mr. Stefan Ziegler will continue in his role as CEO of Takeda Pharmaceuticals Asia Private Limited. Mr. Ziegler is responsible for oversight
'/>"/>

SOURCE Takeda Pharmaceutical Company Limited
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Takeda Receives New Information on Alogliptin (SYR-322) NDA
2. Healthcare Businesswomens Association Announces 2009 Woman of the Year, Dr. Deborah Dunsire, President and CEO of Millennium: The Takeda Oncology Company
3. Welvista Announces Partnering with Takeda to Provide Medication at No Cost to the Uninsured
4. Review of Takedas Febuxostat New Drug Application Continues Past PDUFA Date
5. FDA Adds Three Months to Review of Takedas New Drug Application for TAK-390MR
6. Takedas investigational PPI TAK-390MR demonstrated higher healing rates compared to lansoprazole
7. Takeda Completes Acquisition of Millennium
8. Takeda Commences Cash Tender Offer for all Outstanding Shares of Millennium
9. Takeda, Abbott Announce Plans to Conclude TAP Joint Venture
10. Takeda Announces New U.S. Leadership
11. Takeda submits new drug application for alogliptin (syr-322) in the US
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/9/2014)... most common type of lung cancer, researchers have uncovered ... in forming tumors. The new knowledge may expand treatments ... changes already are available or are in clinical trials. ... from The Cancer Genome Atlas (TCGA), including researchers at ... Medical School and other institutions, studied tumors from 230 ...
(Date:7/9/2014)... in policing injection drug users in Russia might ... , A study, conducted by researchers from Boston ... collaboration with St. Petersburg Pavlov State University, sought ... the health outcomes of a cohort of HIV-positive ... Those who were arrested by police were more ...
(Date:7/9/2014)... There has been a sharp increase in the ... using MyChart, the online, interactive service that allows patients ... healthcare providers, schedule appointments, and renew prescriptions. , Over ... MyChart each year increased five-fold, while the ... 10-fold, according to a study by Dr. David ...
(Date:7/9/2014)... and have a reputation for being highly toxic, but when ... being being found to offer potential health benefits in a ... dementia. A new compound (AP39), designed and made at the ... by targeting delivery of very small amounts of the substance ... Scientists in Exeter have already found that the compound protects ...
(Date:7/9/2014)... prescription labels handed out by pharmacists may be ... medication, according to new research by the University ... the Blind)., The study, published recently in the ... on prescription medications dispensed by pharmacies do not ... By simply following recommended guidelines for font size, ...
Breaking Medicine News(10 mins):Health News:Lung cancer study hints at new treatments 2Health News:BU researchers relate arrests with HIV risk environment 2Health News:MyChart use skyrocketing among cancer patients, UT Southwestern study finds 2Health News:MyChart use skyrocketing among cancer patients, UT Southwestern study finds 3Health News:Rotten egg gas holds key to healthcare therapies 2Health News:Most prescription labels fail to meet guidelines, risking dosage errors 2
... French . Robot-assisted surgery dramatically improves outcomes ... researchers at the Jewish General Hospital,s Lady Davis Institute ... post-operative complications and shorter hospital stays, robotic procedures also ... late 2010 in a series of studies in ...
... , WEDNESDAY, Jan. 12 (HealthDay News) -- People who have ... after receiving the results, whether they are positive or negative, ... or get screening tests that might modify that risk, despite ... in the Jan. 13 issue of the New England ...
... of Science (AAAS) has elevated four Dartmouth professors to the ... Dartmouth Medical School. Medical School faculty members Charles ... MD, join Dartmouth biologist C. Robertson McClung among the 504 ... eight other Dartmouth researchers to have earned the distinction. ...
... Jan. 12 (HealthDay News) -- Research in rats suggests that ... by persistent ringing or other noises in the ears. ... a result of hearing loss. In this study, U.S. ... variety of sound tones over an extended period of time. ...
... cancer with a relatively high degree of accuracy when applied ... cancer, according to a study in the January issue of ... was performed at the University of Washington and Seattle Cancer ... with 592 patients who were recently diagnosed with breast cancer ...
... Scientists are reporting a scientific basis for the long-standing belief ... other countries can prevent and treat cataracts, a clouding of ... of vision loss worldwide. Their study appears in Inorganic ... Wu, Fu-Yung Huang, Shih-Hsiung Wu and colleagues note that eye ...
Cached Medicine News:Health News:Robotic surgery of 'tremendous benefit' to patients, say JGH researchers 2Health News:Consumer Genetic Testing May Not Boost Users' Anxiety 2Health News:Consumer Genetic Testing May Not Boost Users' Anxiety 3Health News:Dartmouth Medical School faculty named fellows of the American Association for the Advancement of Science 2Health News:Animal Study Finds Nerve Stimulation May Thwart Tinnitus 2
(Date:1/15/2014)... 15, 2014  Valeant Pharmaceuticals International, Inc. (NYSE: ... waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of ... offer by its indirect wholly-owned subsidiary, Sapphire Subsidiary Corp. ... stock of Solta Medical, Inc. (NASDAQ: SLTM ...
(Date:1/15/2014)... YORK , Jan. 15, 2014 ... market research report is available in ... Global Markets and Technologies for Advanced ... Routes of Administration ...
(Date:1/15/2014)... 15, 2014  A novel wearable injector slightly larger than an ... patients to self-inject prescription drugs in the large doses required ... diseases, autoimmune deficiencies, and genetic disorders.  An ... by 2018, according to analysts.   Many of these drugs will ...
Breaking Medicine Technology:Valeant Pharmaceuticals Announces Receipt Of Antitrust Clearance For Its Previously Announced Acquisition Of Solta Medical, Inc. 2Valeant Pharmaceuticals Announces Receipt Of Antitrust Clearance For Its Previously Announced Acquisition Of Solta Medical, Inc. 3Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 2Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 3Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 4Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 5Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 6Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 7Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 8Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 9Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 10Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 11Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 12Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 13Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 14Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 15Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 16Enable Injections Presents A New Class of Injectors for Drug Delivery at PEPTalk, Drug Delivery Partnership Meetings 2
... Misonix, Inc. (NASDAQ: MSON ), a ... therapeutic ultrasonic products worldwide for wound debridement, cosmetic surgery, ... today announced that it has sold its Laboratory and ... million in cash plus a potential additional payment of ...
... 2011 Sectra to Demonstrate its Multi-Modality ... Conference (BIC ) in Orlando, FL from ... company,  Sectra   (NASDAQ OMX Stockholm: ... Monument Radiology, Richmond, VA, to provide its multi-modality Breast Imaging PACS. ...
Cached Medicine Technology:Misonix Announces the Sale of Its Laboratory and Forensic Safety Products Business for $1.5 Million 2Sectra to Provide Breast Imaging PACS to Allison Breast Center at Monument Radiology 2
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: